Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
“We moeten ons niet in slaap laten sussen door ons goede antibioticabeleid”
jul 2019 | Antibioticaresistentie